lutein has been researched along with dalcetrapib in 1 studies
| Studies (lutein) | Trials (lutein) | Recent Studies (post-2010) (lutein) | Studies (dalcetrapib) | Trials (dalcetrapib) | Recent Studies (post-2010) (dalcetrapib) |
|---|---|---|---|---|---|
| 2,770 | 267 | 1,422 | 166 | 38 | 103 |
| Protein | Taxonomy | lutein (IC50) | dalcetrapib (IC50) |
|---|---|---|---|
| Cholesteryl ester transfer protein | Homo sapiens (human) | 4.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaput, E; Durrwell, A; Mary, JL; Niesor, EJ; Staempfli, A; Stauffer, A; Topp, A; Wang, H | 1 |
1 other study(ies) available for lutein and dalcetrapib
| Article | Year |
|---|---|
Effect of compounds affecting ABCA1 expression and CETP activity on the HDL pathway involved in intestinal absorption of lutein and zeaxanthin.
Topics: Amides; Animals; ATP Binding Cassette Transporter 1; Caco-2 Cells; Cholesterol Ester Transfer Proteins; Cricetinae; Esters; Humans; Hydrocarbons, Fluorinated; Intestinal Absorption; Lipoproteins, HDL; Liver; Lutein; Oxazolidinones; Sulfhydryl Compounds; Sulfonamides; Tissue Distribution; Zeaxanthins | 2014 |